INTRODUCTION
A child’s feeding plays a key role in its health and development both during infancy and later in life. Breastfeeding is a natural way of feeding infants, providing all the necessary nutrients, growth factors, bioactive molecules, as well as antibodies and immunological factors supporting the development of the immune system. Breastfed infants are less likely to suffer from metabolic disorders, including obesity and diabetes, later in life, and are characterised by better cognitive development. Breastfeeding also has a beneficial effect on the mother’s health, reducing the risk of cancer, obesity, and other cardiometabolic disorders [1]. Modified milk feeding, often called formula feeding, involves feeding an infant a specially formulated product that attempts to mimic the composition of the breast milk, but is based on cow’s and/or other animal milk, or other ingredients, which are suitable for infant feeding. Feeding with modified milk may be necessary for mothers who face specific medical and social issues, or due to the specific health needs of the baby. The formulas are classified based on caloric density, carbohydrate source, and protein composition. All types of formulas should meet the standards adopted by the Codex Alimentarius Commission (CAC), which is the central part of the Joint FAO/WHO Food Standards Programme [2].
This article provides an overview of the advantages of breastfeeding for infants and their mothers according to the current state of knowledge.
DATA SOURCE
We searched PubMed and Google Scholar databases using the major keywords: ‘breastfeeding’, ‘formula feeding’, ‘human breast milk’, ‘advantages of breastfeeding’, ‘maternal health’, and ‘infant health’. The other key words used for searching are presented in Diagram 1. Selection and eligibility criteria were based on the title and content of abstracts, exclusion of case reports, conference abstracts, letters, and editorial articles. Based on the number of citations and journal impact factor, we limited our search to the most essential and current publications, including observational studies, clinical trials, and meta-analysis studies in the English language. After screening articles, we ended up with 63 articles that were relevant to our paper.
IMPACT OF BREASTFEEDING ON CHILD HEALTH
Breast milk is ideally suited to the needs of the developing infant, providing an adequate caloric load and easily digestible forms of nutrients, growth and immune factors. Therefore, exclusive feeding with human milk for the first 6 months of life, with continued breastfeeding, together with complementary foods, up to 2 years of age or beyond, remains the preferred mode of infant feeding [3, 4].
HUMAN BREAST MILK AS AN OPTIMAL NUTRITION
Human breast milk nutrients are easily digestible and highly absorbable. There are several factors present in a human milk that contribute to this favourable situation: high-quality proteins in the form of easily digestible peptides and amino acids, the right proportions of different types of fats (e.g. omega-3 and omega-6 acids), the presence of digestive enzymes supporting digestion of fats and carbohydrates, the presence of lactose, which facilitates the absorption of calcium, and the presence of lactoferrin and vitamin C, which increase the absorption of iron.
The main nutritional and non-nutritional components of human milk include the following:
• Proteins: casein, α-lactalbumin, lactoferrin, lactadherin, CCL28 mucosal chemokine (C-C Motif Chemokine Ligand 28, CCL28), complement component 3 (C3) and fibronectin, serum albumin, lysozyme, defensins, and immunoglobulins, which play a key role in strengthening the infant’s immune system [5].
• Carbohydrates: mainly in the form of lactose, which is the main energy source for the growing infant’s body. Human milk oligosaccharides (HMOs) belong to the most abundant components of human milk. Although HMOs are non-nutritive to the infant, they play a crucial role as prebiotics preventing pathogen adhesion and modifying gut microbiota [5].
• Fats: in the form of saturated- (SFA), monounsaturated-(MUFA), and polyunsaturated fatty acids (PUFA). Although the latter represents only 15% of the total lipid load, their health-promoting function is unquestionable, because PUFAs are important for the development of the infant’s brain and peripheral nervous system, retina, and immune system [6].
• Vitamins and minerals: A, C, D, E, K, B group, iron, calcium, zinc, iodine, and many others that are essential for the growth and development of the infant as they strengthen bones, heal wounds, boost the immune system, and repair cellular damage. They also participate in haemopoiesis, haemostasis, neurodevelopment, and the conversion of food into energy. However, human milk contains low quantities of vitamins K and D. Therefore, to prevent disorders resulting from their insufficiency, current paediatric recommendations indicate the necessity of postnatal vitamin D and K supplementation of breastfed infants [7].
• Hormones and growth factors: these support the development and growth of the child’s organs (e.g. insulin, insulin-like growth factor [IGF], growth hormone [GH], epidermal growth factor [EGF], fibroblast basic growth factor [FBGF], hepatocyte growth factor [HGF], nerve growth factor [NGF], and erythropoietin [EPO]), control metabolic functions, and participate in the programming of energy balance regulation in childhood (e.g. insulin, ghrelin, leptin, resistin, and adiponectin) [8]. Human milk hormones also have immune effects (e.g. cytokines and chemokines activating Th1- and Th2-responses or playing roles as regulatory and immunoregulatory factors) [9].
• Prebiotics: HMOs, glycans, and other bioactive components, including mucins, promote the development of a healthy microbiome in the infant’s digestive tract that benefits the immune system, digestion, and brain-gut axis [5].
It is worth noting that the nutritional composition of breast milk can change depending on several factors, such as the mother’s age, diet, health status, and stage of lactation. Additionally, it has been shown that breastfeeding is characterised by the daily changes of human milk composition. Various components, including fats, individual amino acids, iron, cortisol, or melatonin, exhibit daily fluctuations that may contribute to the synchronisation of the child’s metabolism and maturation of the internal circadian system [10]. This type of chrononutrition is obviously not present in formula-fed infants.
IMMUNE-BOOSTING PROPERTIES OF HUMAN MILK
Breast milk contains antibodies that are transferred from mother to child. The most important immunoglobulins in breast milk are IgA, IgG, and IgM. IgA plays a key role in protecting mucous membranes (via neutralisation of microorganisms and inhibition of their adhesion to host cells) in the respiratory tract and gastrointestinal system, which are the main entry routes for pathogens. Breast milk also contains various immunological factors, such as glycoproteins and cytokines. The major glycoproteins, such as lactoferrin and lactadherin, can participate in innate immunity by blocking pathogen adhesion to host cells and protecting immature infants against infection and excessive inflammatory response. Lactoferrin exhibits antibacterial, antiviral, antifungal, and antiparasitic properties, while lactadherin protects from rotavirus infection and accelerates healing of the intestinal injury in infants [9]. Lysozyme, another glycoprotein in human milk, demonstrates bacteriolytic properties destroying bacterial walls with particularly strong activity against gram-positive bacteria. Lysozyme is also known to have antiviral and anti-inflammatory properties [9]. Human milk cytokines act as potent messengers influencing the immune activity of the infant body. The most abundant anti-inflammatory cytokines in the breast milk are IL-4, IL-7, IL-10, IL-13, IL-18, growth transforming factor β (TGF–β), and granulocyte-colony stimulating factor (GCSF), while inflammatory cytokines include IL-2, IL-5, IL-6, IL-8, IL-12, interferon γ (INFγ), and tumour necrosis factor α (TNF-α) [5, 10].
Human breast milk contains various immune-competent cells that contribute to both innate (macrophages and neutrophils, NK cells) and adaptive immunity (CD8+ and CD4+ T cells, B cells, plasma cells). Additionally, under physiologic conditions, human milk contains up to 4 log10 colony-forming units (cfu)/mL bacteria, which facilitate the establishment of the “healthy” and diverse gut microbiota. The 2 species Bifidobacterium and Lactobacillus are particularly important because of their potential probiotic roles. They modulate immune response via improvement of intestinal barrier function, competitive pathogen exclusion from gut epithelia, direct production of antimicrobial factors, or interaction with immune cells. Therefore, they may participate in the treatment of various infectious, allergic, and inflammatory conditions such as diarrhoea due to viral or bacterial infections [11].
Human breast milk is a rich source of circulating microRNA (miRNA) that can exert beneficial regulatory function in diverse gene expression, cell growth, metabolism, and immunity [12].
BREAST MILK AND THE RISK OF ALLERGY AND FOOD INTOLERANCE
Research has shown that proteins present in human breast milk have low allergenic potential; however, small amounts of food protein from the mother’s diet may pass through into breast milk. Even though food proteins in human milk can trigger allergic reactions in infants with IgE-mediated food allergies, the probability of an IgE-mediated allergic reaction is low [13]. For infants who are genetically predisposed to food allergies, less allergenic proteins play a key role in shaping immune tolerance, which may help to reduce the risk of food allergies. Antibodies present in breast milk, especially IgA, participate in protecting the infant’s gastrointestinal tract from excessive activation of the immune system in response to food antigens. Additionally, HMOs promote the development of the mucosal immune system and colonic microbiota of the infant [14]. However, some researchers indicate that, depending on individual variations in breast milk composition, the allergy-preventing effect of breastfeeding may vary from one mother to another.
Based on a recently published study, low-grade quality evidence exists that longer duration of breastfeeding is associated with (1) reduced risk of asthma in children aged 5–18 years, (2) reduced risk of allergic rhinitis in children up to 5 years of age, and reduced risk of eczema in children up to 2 years of age [15]. The latest clinical report from the American Academy of Pediatrics on the prevention of an infant atopic disease states that exclusive breastfeeding for 3 to 4 months reduces the incidence of eczema in the first 2 years of life, while there is no short- or long-term benefit of exclusive breastfeeding beyond 3 to 4 months in preventing atopic disease. In addition, any period of breastfeeding ≥ 3 to 4 months protects against wheezing in the first 2 years of life, and some evidence suggests that longer breastfeeding protects against asthma even after 5 years of age. Also, no conclusions can be drawn about the role of breastfeeding in preventing or delaying the onset of specific food allergies [15].
Similar findings apply to the Australasian Society of Clinical Immunology and Allergy (ASCIA) guidelines: Infant Feeding and Allergy Prevention, which states that breastfeeding during the period from around 6 months may help reduce the risk of the infant developing allergies, although evidence for this is low [16].
It is worth remembering that the risk of allergies and food intolerances is complex and can be triggered by various genetic, environmental, and dietary factors.
BREAST MILK AND NERVOUS SYSTEM DEVELOPMENT
Breast milk feeding has a beneficial effect on infants’ brain and nervous system development [17]. Factors that benefit brain and nervous system development refer to the following:
• Omega-3 fatty acids, especially docosahexaenoic acid (DHA) and omega-6 fatty acids, e.g. arachidonic acid. DHA is a key structural component of the brain and retina. Providing sufficient DHA through breast milk can support normal brain development, including thought processes, memory, visual perception, and cognitive function in infants.
• Phospholipids that are essential for the proper functioning of nerve cells, nerve transmission, and the synthesis and transport of neurotransmitters.
• Growth factors, including nerve growth factor (NGF) and insulin-like growth factor I (IGF-1), which influence neurogenesis and the processes associated with neuronal plasticity.
• Micronutrients, such as iron, zinc, copper, and selenium that are essential for brain and nervous system development, neural transmission, and metabolism.
• Bioactive molecules, including miRNA, carotenoids, choline, taurine, and carnosine, that affect nervous system structure and function (e.g. carotenoids, especially lutein, can improve neuronal transmission and protect neurons against oxidative damage; choline is a precursor of neurotransmitters and a structural component of cell membranes).
However, because randomised trials comparing the impact of breastfeeding with formula feeding on neuro-development cannot be done, many confounding variables must be taken into consideration (e.g. maternal and paternal IQ, social status, educational level, stress, child variables, and abnormal neurologic testing). Therefore, it is hard to clearly conclude that breastfeeding significantly improves developmental and cognitive outcomes. The exception is the neurodevelopmental advantage in premature infants fed breast milk [18].
BREAST MILK LOWERS THE RISK OF OBESITY AND CHRONIC DISEASES LATER IN LIFE
Breastfeeding is associated with a lower risk of obesity and chronic diseases in childhood and later in life. Breastfeeding allows the infant to control its food intake, which promotes proper regulation of appetite and satiety. Breastfed infants tend to consume an amount of food according to their actual needs, which can reduce the risk of food overconsumption, unhealthy feeding patterns, and obesity in later life. Moreover, there is an association between a longer duration of breastfeeding and a lower risk of overweight and obesity in childhood and adulthood [19].
Breastfeeding is associated with more favourable levels of hormones responsible for appetite regulation, metabolism, and energy management. This can contribute to maintaining a healthy phenotype and normal body weight of the baby. It has been shown that fasting insulin and the risk of insulin resistance are reduced in both breastfed children and their mothers [20], while leptin concentrations remain elevated in breastfed infants, which partially depends on its presence in human milk [21]. Leptin in its normal concentrations works as a satiety factor that strongly participates in signalling whole-body energy balance and metabolic functions, including the inhibition of appetite and prevention of hyperinsulinaemia [21]. Although the leptin level correlates with anthropometric parameters, its direct effect on children’s body weight later in life is not fully understood [22].
The nutritional programming of healthy body weight and metabolic balance is also associated with the bacterial diversity of an infant’s gut microbiota. Knowing that dysbiosis during infancy is related to obesity later in life [23], it is worth remembering that breast milk contains prebiotics, which promote the development of a healthy microbiome in the infant’s intestines.
All these factors contribute to the lower risk of obesity and obesity-related chronic diseases such as insulin resistance, type 2 diabetes, coronary artery disease, hypertension, and some types of cancer.
BREAST MILK LOWERS THE RISK OF CANCER
Human breast milk contains anticancer components that may induce programmed cell death of tumour cells. Breast milk-derived cytotoxic protein-fatty acid complex, called HAMLET (human alpha-lactalbumin made lethal to tumour cells), which contains alpha-lactalbumin and oleic acid, accumulates in the nucleus, triggering an apoptosis of cancer cells [24]. The other substances capable of apoptotic signalling include TRAIL – a cytokine derived from colostrum (TNF-related apoptosis inducing ligand), human milk kappa-casein, and lactoferrin [25].
BREAST MILK PLAYS A ROLE AS AN EPIGENETIC REGULATOR OF HEALTH AND DISEASE
Studies have shown that breast milk participates in the removal of damaged DNA and in tissue repair. The following mechanisms are currently proposed to explain this beneficial effect:
Breast milk boosts the immune system, allowing for more efficient elimination of damaged cells and tissue regeneration.
Breast milk is rich in antioxidants, which help to combat the formation of reactive oxygen species (ROS) and oxidative stress, which modify the structure of DNA and induce DNA fragmentation [26]. Oxidation of DNA is highly mutagenic and may be the basis for mutations, carcinogenesis, apoptosis, necrosis, and hereditary diseases. Antioxidants in breastmilk include endogenous enzymes capable of eliminating free radicals (superoxide dismutase [SOD], catalase, glutathione peroxidase [GPx]), Glutathione system, food-derived antioxidants (e.g. vitamin E and vitamin C), and the major hormonal free radical scavenger – melatonin [27].
Circulating in breast milk, miRNA may participate in apoptosis or DNA repair [5].
Breast milk might influence DNA methylation through the effects of some of its nutritional components that contain methyl group (e.g. choline, folate, methionine). The process of DNA methylation and demethylation is one of the mechanisms that regulate gene expression, participate in the programming metabolic health of the offspring, and may affect the repair of damaged DNA. Based on an epigenome-wide association study (EWAS), several DNA islands have been identified as regions of the methylome associated with breastfeeding, including methylation in the cg11414913 CpG, or cg05800082 CpG [28], and genes involved in fat metabolism (RXRA), appetite control (LEP), growth and metabolism (IGF2), and maintenance of DNA methylation marks (DNMT1) [28]. It has been shown that obesity-related gene methylation status affects the link between breastfeeding and long-term outcomes, e.g. obesity development. Breastfeeding might be associated with methylation of the LEP (negatively), RXRA (positively), and IGF2 (negatively), modulating the gene expression level and lowering adiposity in young children and neonates [29].
Some of the bioactive proteins in breast milk, including lactoferrin, or growth factors, may show the ability to repair damaged DNA. Apart from indirect activities, lactoferrin directly affects transcription factors, gene expression, cell cycle, and differentiation, and it participates in the elimination of cancer cells [30].
Human milk stem cells have the ability to differentiate into various cell lineages, including cells involved in the repair of damaged DNA [31]. Stem cells may also act as epigenetic regulators because they contain bioactive molecules, such as miRNA [7].
BREASTFEEDING HELPS TO PREVENT SUDDEN INFANT DEATH SYNDROME (SIDS)
Although observational studies cannot prove causation and randomised trials cannot be done, the strong association between breastfeeding and significantly reduced risk of SIDS has been confirmed [32]. Better immunity and fewer infections affecting the respiratory system as well as being a light sleeper are the 2 postulated mechanisms related to breastfeeding’s protective role [32].
IMPACT OF NATURAL FEEDING ON MATERNAL HEALTH
BREASTFEEDING HELPS MOTHERS TO RECOVER AFTER DELIVERY
Breastfeeding has a positive effect on uterine involution and the reduction of postpartum bleeding. Breastfeeding, via breast-brain neuroendocrine reflex, stimulates the hypothalamic production of oxytocin, which promotes the uterus contractions and speeds up its involution process. Additionally, intense uterus contractions participate in the constriction of the blood vessels where the placenta has been detached, which reduces excessive postpartum bleeding and iron loss.
BREASTFEEDING REDUCES THE RISK OF BREAST, OVARIAN, AND ENDOMETRIAL CANCER
Breastfeeding is associated with a reduced risk of the most lethal type of ovarian cancer (OC) – a high-grade serous cancer. Interestingly, longer duration of breastfeeding and older age at the first and last breastfeeding episode are both inversely related to the risk of OC [33].
There are many factors and mechanisms that possibly contribute to this beneficial relationship:
• Breastfeeding leads to the reflex suppression of pituitary gonadotropins, especially luteinising hormone (LH), which is considered to be a one of the potential causal mechanisms of OC [34]. Moreover, inhibition of LH caused by breastfeeding suppresses ovulatory cycles and ovulation-induced trauma, apoptosis, and regenerative repair at the site of ovulation. In regularly ovulating women these processes predispose ovarian surface epithelial cells to carcinogenesis [34].
• Decreased number of lifetime ovulatory cycles limits the exposure of healthy cells to oestrogens, which are known to exhibit genotoxic and mitogenic effects [35].
• High levels of oxytocin protect against cancer because oxytocin exhibits anti-proliferative, anti-migratory, and anti-invasive properties possibly via anti-inflammatory mechanisms [36].
• Breast milk demonstrates anticancer properties with the use of anti-infective, antioxidant, immunomodulatory, and anti-inflammatory factors. Some of them specifically promote programmed tumour cell death (e.g. HAMLET or TRAIL) providing effective protection against the development of breast cancer [24, 25].
BREASTFEEDING FACILITATES POSTPARTUM WEIGHT LOSS
Most studies report that natural feeding has a positive effect on postpartum weight loss, playing a protective role against obesity/overweight and obesity-related diseases. During the first 6 months postpartum, exclusively breastfeeding mothers, as compared with formula-and mixed-feeders, benefit significantly more from decreasing postpartum weight [37]. This beneficial effect may result from the following:
• Extra energy expenditure. The average energy cost for milk production accounts for about 25% of the resting energy requirement during lactation [38].
• Endocrine factors that favour lipolysis, and their combined action in the maternal organism. These include the following: decreased basal insulin levels, which is associated with lowered lipogenesis, mutual effects of prolactin and leptin on their secretion resulting in stimulated galactogenesis, energy expenditure (prolactin) and anorexigenic effect (leptin), decreased levels of cortisol, and increased secretion of brain cholecystokinin both resulting in appetite inhibition [20].
However, some studies reported a lack of association between breastfeeding and maternal weight [38]. Any discrepancies in this field are due to the mother’s physical activity, genetics, diet, body weight before pregnancy and weight gained during pregnancy, caloric intake/restriction, and duration and intensity of breastfeeding.
PROTECTION AGAINST CARDIOMETABOLIC DISEASES AND OSTEOPOROSIS
Women who breastfeed may benefit from protection against the onset of ischaemic heart disease, hypertension, stroke, maternal type 2 diabetes, and rheumatoid arthritis [39, 40]. Regular breastfeeding may lower blood lipid levels, improve glucose metabolism and insulin sensitivity, reduce body weight, and exhibit anti-inflammatory properties, which translates into cardiovascular benefits.
Also, although the nursing mother’s body uses bone calcium reserves for milk production, breastfeeding may reduce the risk of osteoporosis in later life [41]. When the diet is adequately balanced in terms of calcium, the efficiency of calcium absorption and utilisation increases, which can contribute to bone strengthening.
However, some investigators indicated a negative association between the duration of breastfeeding and bone density in perimenopausal women [42], while others showed no significant impact [43]. These discrepancies may result from different designs of studies, duration of lactation, and different maternal factors such as age, parity, nutritional status and dietary behaviour, stage of menopausal transition, ethnicity, and others [44].
EMOTIONAL BENEFITS AND BONDING BETWEEN MOTHER AND CHILD
Breastfeeding enhances maternal-infant bonding and empathic behaviour and protects the mother from lowered mood and postpartum depression, possibly via strong anxiolytic and stress-reducing properties of oxytocin and prolactin [45]. In addition, during early motherhood (up to 6 months after delivery) exclusively breastfeeding women, when compared with formula feeders, are less fatigued and experience better sleep patterns [46].
EFFECT OF FEEDING MODIFIED MILK ON BABY’S HEALTH
Feeding with modified milk is a convenient solution to share feeding responsibilities between caregivers when maternal milk is unavailable. However, situations when formula feeding is recommended instead of breastfeeding are rare. According to the American Academy of Pediatrics, contraindications to breastfeeding include the following: infants with classic galactosaemia, mothers, in the US, who are infected with human immunodeficiency virus (HIV), untreated brucellosis, or suspected or confirmed Ebola virus disease, mothers using substances such as opioids, cocaine, and PCP (phencyclidine), mothers who are positive for human T-cell lymphotropic virus type I or II, mothers with active (infectious) untreated tuberculosis, and mothers with active herpes simplex lesions on the breast [47].
Modified milk attempts to mimic human breast milk composition, but it offers far fewer benefits than human breast milk and, therefore, could be accompanied by several health risks. The exception is vitamin K and vitamin D content, which is low in breast milk and sufficient in formulas [7]. Apart from being deficient in immune factors, formula feeding is associated with risks of severe infectious diseases because powdered infant formula is not a sterile product. Some of the pathogens contaminate formula milk during the manufacturing process and/or during formula preparation and storage at home [48]. As reported by health authorities, formula contamination with Salmonella enterica and/or Enterobacter sakazakii are of greatest concern because there is clear evidence of causality linking formula contamination with these bacteria with life-threating illness in infants [49].
on the volume of milk remaining in the bottle, formula feeding may give the impression of a perfect opportunity to monitor and adjust the amount of food according to the baby’s appetite and needs. However, several studies confirmed that the feeding method, among other factors shaping feeding behaviour, impacts feeding behaviours and patterns of hunger [50]. Formula-fed infants experience rapid and often excessive weight gain due to dysregulation of hunger-satiety cues [51], while breastfeeding is related to greater appetite regulation and obesity-protective eating behaviours throughout childhood [52].
CONCLUSIONS
Breastfeeding is characterised by its unique health advantages for both mother and child. However, some mothers still decide to choose infant formula as an acceptable alternative. Therefore, extending the knowledge about the benefits of natural feeding is required.
DISCLOSURE
The authors report no conflict of interest.
References
1. Mantzorou M, Papandreou D, Vasios GK, et al. Exclusive breastfeeding for at least four months is associated with a lower prevalence of overweight and obesity in mothers and their children after 2-5 years from delivery. Nutrients 2022; 14(17): 3599. DOI: 10.3390/nu14173599.
2.
CODEX ALIMENTARIUS. Standard for infant formula and formulas for special medical purposes intended for infants. CXS 72-1981, amended in 2020. Available from: https://www.fao.org/fao-who-codexalimentarius/sh-proxy/en/?lnk=1&url=https%253A%252F%252Fworkspace.fao.org%252Fsites%252Fcodex%252FStandards%252FCXS%2B72-1981%252FCXS_072e.pdf (accessed: 10 February 2024).
3.
Global strategy for infant and young child feeding. WHO, 2003. Available from: http://apps.who.int/iris/bitstream/handle/ 10665/42590/9241562218.pdf;jsessionid=FD6AD2B9C7898BEA22C8CA9C2C8272E0?sequence=1 (accessed: 10 February 2024).
4.
Szajewska H, Horvath A, Rybak A, et al. Zasady żywienia zdrowych niemowląt. Stanowisko Polskiego Towarzystwa Gastroenterologii, Hepatologii i Żywienia Dzieci Nutrition of healthy term infants [Recommendations of the Polish Society for Paediatrics Gastroenterology, Hepatology and Nutrition]. Standardy Medyczne/Pediatria 2021; 18: 7-24.
5.
Yi DY, Kim SY. Human breast milk composition and function in human health: from nutritional components to microbiome and microRNAs. Nutrients 2021; 13(9): 3094. DOI: 10.3390/nu13093094.
6.
Pietrzak-Fiećko R, Kamelska-Sadowska AM. The comparison of nutritional value of human milk with other mammals’ milk. Nutrients 2020; 12(5): 1404. DOI: 10.3390/nu12051404.
7.
Kim SY, Yi DY. Components of human breast milk: from macronutrient to microbiome and microRNA. Clin Exp Pediatr 2020; 63(8): 301-309.
8.
Boix-Amorós A, Collado MC, Van’t Land B, et al. Reviewing the evidence on breast milk composition and immunological outcomes. Nutr Rev 2019; 77(8): 541-556.
9.
Italianer MF, Naninck EFG, Roelants JA, et al. Circadian variation in human milk composition, a systematic review. Nutrients 2020; 12(8): 2328. DOI: 10.3390/nu12082328.
10.
Kiełbasa A, Gadzała-Kopciuch R, Buszewski B. Cytokines- biogenesis and their role in human breast milk and determination. Int J Mol Sci 2021; 22(12): 6238. DOI: 10.3390/ijms22126238.
11.
Togo A, Dufour JC, Lagier JC, et al. Repertoire of human breast and milk microbiota: a systematic review. Future Microbiol 2019; 14: 623-641.
12.
Carrillo-Lozano E, Sebastián-Valles F, Knott-Torcal C. Circulating microRNAs in breast milk and their potential impact on the infant. Nutrients 2020; 12(10): 3066. DOI: 10.3390/nu12103066.
13.
Gamirova A, Berbenyuk A, Levina D, et al. Food proteins in human breast milk and probability of IgE-mediated allergic reaction in children during breastfeeding: a systematic review. J Allergy Clin Immunol Pract 2022; 10(5): 1312-1324.e8.
14.
Zuurveld M, van Witzenburg NP, Garssen J, et al. Immunomodulation by human milk oligosaccharides: the potential role in prevention of allergic diseases. Front Immunol 2020; 11: 801. DOI: 10.3389/fimmu.2020.00801.
15.
Greer FR, Sicherer SH, Burks AW; American Academy of Pediatrics Committee on Nutrition; American Academy of Pediatrics Section on Allergy and Immunology. Effects of early nutritionalinterventions on the development of atopic disease in infants and children: the role of maternal dietary restriction, breastfeeding, timing of introduction of complementary foods, and hydrolyzed formulas. Pediatrics 2008; 121(1): 183-191.
16.
Joshi PA, Smith J, Vale S, Campbell DE. The Australasian society of clinical immunology and allergy infant feeding for allergy prevention guidelines. Med J Aust 2019; 210(2): 89-93.
17.
Lockyer F, McCann S, Moore SE. Breast milk micronutrients and infant neurodevelopmental outcomes: a systematic review. Nutrients 2021; 13(11): 3848. DOI: 10.3390/nu13113848.
18.
Brown JV, Lin L, Embleton ND, et al. Multi-nutrient fortification of human milk for preterm infants. Cochrane Database Syst Rev 2020; 6(6): CD000343. DOI: 10.1002/14651858.CD000343.pub4.
19.
Ferreira AV, Rosendo I, Santiago LM, Simões JA. Breastfeeding and childhood obesity in the Azores. Fam Med Prim Care Rev 2021; 23(1): 81-86.
20.
Nurek J, Wiśniewski OW, Kupsz J, et al. Hormones regulating energy homeostasis in breastfeeding versus formula feeding mothers. J Physiol Pharmacol 2021; 72(5): 731-739.
21.
Juan Castell MF, Peraita-Costa I, Soriano JM, et al. A review of the relationship between the appetite-regulating hormone leptin present in human milk and infant growth. Breastfeed Med 2022; 17(2): 98-111.
22.
Warchoł M, Wojciechowska M, Kupsz J, et al. Association of cord blood ghrelin, leptin and insulin concentrations in term newborns with anthropometric parameters at birth. J Pediatr Endocrinol Metab 2018; 31(2): 151-157.
23.
de Cuevillas B, Milagro FI, Tur JA, et al. Fecal microbiota relationships with childhood obesity: a scoping comprehensive review. Obes Rev 2022; 23 (Suppl 1): e13394. DOI: 10.1111/obr. 13394.
24.
Dopierała K, Krajewska M, Prochaska K. Binding of α-lactalbumin to oleic acid monolayer and its relevance to formation of HAMLET-like complexes. Int Dairy J 2018; 89: 96-104.
25.
Su Q, Sun X, Zhu L, et al. Breastfeeding and the risk of childhood cancer: a systematic review and dose-response meta-analysis. BMC Med 2021; 19(1): 90. DOI: 10.1186/s12916-021-01950-5.
26.
Juan CA, Pérez de la Lastra JM, Plou FJ, Pérez-Lebeña E. The chemistry of reactive oxygen species (ROS) revisited: outlining their role in biological macromolecules (DNA, lipids and proteins) and induced pathologies. Int J Mol Sci 2021; 22(9): 4642. DOI: 10.3390/ijms22094642.
27.
Gila-Diaz A, Arribas SM, Algara A, et al. A review of bioactive factors in human breastmilk: a focus on prematurity. Nutrients 2019; 11(6): 1307. DOI: 10.3390/nu11061307.
28.
Hartwig FP, Davey Smith G, Simpkin AJ, et al. Association between breastfeeding and DNA methylation over the life course: findings from the Avon longitudinal Study of Parents and Children (ALSPAC). Nutrients 2020; 12(11): 3309. DOI: 10.3390/nu12113309.
29.
Pauwels S, Symons L, Vanautgaerden EL, et al. The influence of the duration of breastfeeding on the infant’s metabolic epigenome. Nutrients 2019; 11(6): 1408. DOI: 10.3390/nu11061408.
30.
Hartwig FP, Loret de Mola C, Davies NM, et al. Breastfeeding effects on DNA methylation in the offspring: a systematic literature review. PLoS One 2017; 12(3): e0173070. DOI: 10.1371/journal.pone.0173070.
31.
Bukowska-Ośko I, Sulejczak D, Kaczyńska K, et al.: Lactoferrin as a human genome “Guardian” – an overall point of view. Int J Mol Sci 2022; 23(9): 5248. DOI: 10.3390/ijms23095248.
32.
Mane S, Taneja S, Madala JS, et al. Study of stem cells in human milk. Cureus 2022; 14(3): e23701. DOI: 10.7759/cureus.23701.
33.
Landa-Rivera JL, Pérez-Pérez J, González-Núñez MDP, et al. Population-based survey showing that breastfed babies have a lower frequency of risk factors for sudden infant death syndrome than nonbreastfed babies. Breastfeed Med 2022; 17(2): 182-188.
34.
Babic A, Sasamoto N, Rosner BA, et al. Association between breastfeeding and ovarian cancer risk. JAMA Oncol 2020; 6(6): e200421. DOI: 10.1001/jamaoncol.2020.0421.
35.
Xiong S, Mhawech-Fauceglia P, Tsao-Wei D, et al. Expression of the luteinizing hormone receptor (LHR) in ovarian cancer. BMC Cancer 2019; 19(1): 1114. DOI: 10.1186/s12885-019-6153-8.
36.
Modugno F, Goughnour SL, Wallack D, et al. Breastfeeding factors and risk of epithelial ovarian cancer. Gynecol Oncol 2019; 153(1): 116-122.
37.
Cuneo MG, Szeto A, Schrepf A, et al. Oxytocin in the tumor microenvironment is associated with lower inflammation and longer survival in advanced epithelial ovarian cancer patients. Psychoneuroendocrinology 2019; 106: 244-251.
38.
Lambrinou CP, Karaglani E, Manios Y. Breastfeeding and postpartum weight loss. Curr Opin Clin Nutr Metab Care 2019; 22(6): 413-417.
39.
Butte NF, King JC. Energy requirements during pregnancy and lactation. Public Health Nutr 2005; 8(7A): 1010-1027.
40.
Tschiderer L, Seekircher L, Kunutsor SK, et al. Breastfeeding is associated with a reduced maternal cardiovascular risk: systematic review and meta-analysis involving data from 8 studies and 1 192 700 parous women. J Am Heart Assoc 2022; 11(2): e022746. DOI: 10.1161/JAHA.121.022746.
41.
Magnus MC, Wallace MK, Demirci JR, et al. Breastfeeding and later-life cardiometabolic health in women with and without hypertensive disorders of pregnancy. J Am Heart Assoc 2023; 12(5): e026696. DOI: 10.1161/JAHA.122.026696.
42.
Kovacs CS. Maternal mineral and bone metabolism during pregnancy, lactation, and post-weaning recovery. Physiol Rev 2016; 96(2): 449-547.
43.
Lee EN, Choe SY, Choi EH, Lee MJ. Effects of parity and breast feeding duration on the risk of osteoporosis in postmenopausal Korean women: a systematic review and meta-analysis. J Menopausal Med 2019; 25(2): 100-107.
44.
Sarantaki A. Breastfeeding and postmenopausal osteoporosis. Gynecol Reprod Health 2021; 5(5): 1-4.
45.
Salari P, Abdollahi M. The influence of pregnancy and lactation on maternal bone health: a systematic review. J Family Reprod Health 2014; 8(4): 135-148.
46.
Thul TA, Corwin EJ, Carlson NS, et al. Oxytocin and postpartum depression: a systematic review. Psychoneuroendocrinology 2020; 120: 104793. DOI: 10.1016/j.psyneuen.2020.104793.
47.
Nurek J, Buraczyńska-Andrzejewska B, Kolasa I, et al. Fatigue, sleepiness, perceived stress and physical activity in postpartum mothers according to the infants’ feeding method. A pilot study. Pediatr Med Rodz 2021; 17(4): 339-345.
48.
Meek JY, Noble L. Section on breastfeeding. Policy statement: breastfeeding and the use of human milk. Pediatrics 2022; 150(1): e2022057988. DOI: 10.1542/peds.2022-057988.
49.
Cahill SM, Wachsmuth IK, Costarrica Mde L, Embarek PKB. Powdered infant formula as a source of Salmonella infection in infants. Clin Infect Dis 2008; 46(2): 268-273.
50.
Henry M, Fouladkhah A. Outbreak history, biofilm formation, and preventive measures for control of Cronobacter sakazakii in infant formula and infant care settings. Microorganisms 2019; 7(3): 77. DOI: 10.3390/microorganisms7030077.
51.
McNally J, Hugh-Jones S, Caton S, et al. Communicating hunger and satiation in the first 2 years of life: a systematic review. Matern Child Nutr 2016; 12(2): 205-228.
52.
Appleton J, Russell CG, Laws R, et al. Infant formula feeding practices associated with rapid weight gain: a systematic review. Matern Child Nutr 2018; 14(3): e12602. DOI: 10.1111/mcn.12602.
This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.